Priority Date: 20.06.12 (KR 20120066333)

NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT

  • Application ID: EP13806654
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company

Attorney

no operation time available
Headquarter in Munich
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Boeters & Lieck is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.06.2012 - Priority Date (KR 20120066333)
  • 27.12.2013 - Publication A1 (WO2013191396)
  • 29.04.2015 - Publication A1 (EP2865664)

IPC Classification